206 related articles for article (PubMed ID: 23490642)
1. L31. A GWAS in ANCA-associated vasculitis: will genetics help re-define clinical classification?
Lyons PA; Smith KG
Presse Med; 2013 Apr; 42(4 Pt 2):589-91. PubMed ID: 23490642
[No Abstract] [Full Text] [Related]
2. L27. Antibodies versus phenotypes: a clinician's view.
Jayne D
Presse Med; 2013 Apr; 42(4 Pt 2):579-82. PubMed ID: 23490640
[No Abstract] [Full Text] [Related]
3. L32. ANCA vasculitis over the world. What do we learn from country differences?
Watts RA; Scott DG
Presse Med; 2013 Apr; 42(4 Pt 2):591-3. PubMed ID: 23481365
[No Abstract] [Full Text] [Related]
4. Immunopathogenesis of ANCA-Associated Vasculitis.
Kronbichler A; Lee KH; Denicolò S; Choi D; Lee H; Ahn D; Kim KH; Lee JH; Kim H; Hwang M; Jung SW; Lee C; Lee H; Sung H; Lee D; Hwang J; Kim S; Hwang I; Kim DY; Kim HJ; Cho G; Cho Y; Kim D; Choi M; Park J; Park J; Tizaoui K; Li H; Smith L; Koyanagi A; Jacob L; Gauckler P; Shin JI
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023023
[TBL] [Abstract][Full Text] [Related]
5. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Merkel PA; Xie G; Monach PA; Ji X; Ciavatta DJ; Byun J; Pinder BD; Zhao A; Zhang J; Tadesse Y; Qian D; Weirauch M; Nair R; Tsoi A; Pagnoux C; Carette S; Chung S; Cuthbertson D; Davis JC; Dellaripa PF; Forbess L; Gewurz-Singer O; Hoffman GS; Khalidi N; Koening C; Langford CA; Mahr AD; McAlear C; Moreland L; Seo EP; Specks U; Spiera RF; Sreih A; St Clair EW; Stone JH; Ytterberg SR; Elder JT; Qu J; Ochi T; Hirano N; Edberg JC; Falk RJ; Amos CI; Siminovitch KA;
Arthritis Rheumatol; 2017 May; 69(5):1054-1066. PubMed ID: 28029757
[TBL] [Abstract][Full Text] [Related]
6. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
[TBL] [Abstract][Full Text] [Related]
8. L34. Neutrophils in ANCA-associated vasculitis: still under investigation.
Witko-Sarsat V
Presse Med; 2013 Apr; 42(4 Pt 2):595-7. PubMed ID: 23481359
[No Abstract] [Full Text] [Related]
9. Genetically distinct subsets within ANCA-associated vasculitis.
Lyons PA; Rayner TF; Trivedi S; Holle JU; Watts RA; Jayne DR; Baslund B; Brenchley P; Bruchfeld A; Chaudhry AN; Cohen Tervaert JW; Deloukas P; Feighery C; Gross WL; Guillevin L; Gunnarsson I; Harper L; Hrušková Z; Little MA; Martorana D; Neumann T; Ohlsson S; Padmanabhan S; Pusey CD; Salama AD; Sanders JS; Savage CO; Segelmark M; Stegeman CA; Tesař V; Vaglio A; Wieczorek S; Wilde B; Zwerina J; Rees AJ; Clayton DG; Smith KG
N Engl J Med; 2012 Jul; 367(3):214-23. PubMed ID: 22808956
[TBL] [Abstract][Full Text] [Related]
10. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
[TBL] [Abstract][Full Text] [Related]
11. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
Holle JU
Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
[No Abstract] [Full Text] [Related]
12. Classification of ANCA-associated vasculitis.
Khan I; Watts RA
Curr Rheumatol Rep; 2013 Dec; 15(12):383. PubMed ID: 24203096
[TBL] [Abstract][Full Text] [Related]
13. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.
Trivioli G; Marquez A; Martorana D; Tesi M; Kronbichler A; Lyons PA; Vaglio A
Nat Rev Rheumatol; 2022 Oct; 18(10):559-574. PubMed ID: 36109667
[TBL] [Abstract][Full Text] [Related]
14. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
[TBL] [Abstract][Full Text] [Related]
15. ANCA-Associated Vasculitis: Core Curriculum 2020.
Geetha D; Jefferson JA
Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.
Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K
Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477
[TBL] [Abstract][Full Text] [Related]
17. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U
Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
[TBL] [Abstract][Full Text] [Related]
19. [ANCA associated vasculitis has genetic components].
Weiss J
Dtsch Med Wochenschr; 2012 Sep; 137(36):1728. PubMed ID: 23281533
[No Abstract] [Full Text] [Related]
20. Rituximab and B-cell return in ANCA-associated vasculitis.
Wilde B; Witzke O; Cohen Tervaert JW
Am J Kidney Dis; 2014 Jun; 63(6):1066. PubMed ID: 24856618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
